MARKET DEFINITION

A balanced diet is necessary for all horses' health, regardless of whether they are employed for breeding, dressage, racing, or displaying. Due to the demands placed on their bodies, performance horses have more food requirements. Equine Pharmaceuticals and Supplements are the products used for the overall well-being of the horse. Equine athletes require nutritional support, such as an energy boost or horse electrolytes to speed up recuperation and replace lost salts. Horse performance supplements offer this help. An equine calming supplement may take hours, days, or weeks to start working, depending on the components and formulation. Even the same components can cause distinct reactions in horses.

MARKET DYNAMICS

There are many different equine supplements on the market, including vitamins, minerals, and protein/amino acid supplements. Horse health and wellness programs increasingly include the use of veterinary medications, particularly herbal supplements. Growing research on the impact of herbal supplements on horse health increased owner preference for herbal products, and increased availability of digestive products and food & energy supplements for equine animals are driving demand for equine supplements and expanding the market for equine supplement products.

REPORT SCOPE

The report titled “Global Equine Pharmaceuticals and Supplements Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Equine Pharmaceuticals and Supplements market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Equine Pharmaceuticals and Supplements market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Equine Pharmaceuticals and Supplements Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION 

The Global Equine Pharmaceuticals and Supplements Market is segmented based on Product Type, Application, Distribution Channel, and region. Based on Product Type, the market has been segmented into Pharmaceuticals and Supplements, whereas based on Pharmaceuticals, the market comprises Anti-Inflammatory, Anti-Ulcer Drugs, Sedative/tranquilizers, and Others, and based on Supplements, the market is divided into Proteins / Amino Acids, Vitamins, Enzymes, Electrolytes & Minerals, Others. Based on Application, the market has been segmented into Thoroughbred Horse, and Others, whereas, the Distribution Channel segmentation includes Third Party E-commerce websites, Company Websites, Specialty Stores, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Equine Pharmaceuticals and Supplements market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Equine Pharmaceuticals and Supplements market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Equine Pharmaceuticals and Supplements market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Equine Pharmaceuticals and Supplements industry in the past three years.

Key players in the Global Equine Pharmaceuticals and Supplements Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

·         Boehringer Ingelheim

·         Merck Animal Health

·         Zoetis

·         Bayer Animal Health

·         Elanco Animal Health

·         Dechra Veterinary Products

·         CEVA

·         Virbac

·         Norbrook Equine

·         Kyoritsu Seiyaku

·         Vetoquinol

·         Protexin Healthcare

·         Audevard

·         Ouro Fino Saude

COVID-19 IMPACT ANALYSIS ON GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

Report Attribute/Metric	Details
Market Size	In USD Million
CAGR	In % (2022-2028)
Base Year	2021
Forecast Period	2022 – 2028
Historical Data	2017 to 2021
Forecast Unit	Value (US$ Mn)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors and Trends
Geographies Covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key Players Analyzed	Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude
Customization & Pricing	Available on Request (10% Customization is Free)

 

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED 

1.    What is the current size of the global Equine Pharmaceuticals and Supplements market?

2.    What will be the growth rate of the market over the forecast period?

3.    Who are the key manufacturers/vendors in the Equine Pharmaceuticals and Supplements market space?

4.    What are the major market opportunities and market risks faced by the market?

5.    What is the impact of COVID-19 on the market?

6.    What are the revenue, sales, and price analysis of the top manufacturers in this market?

7.    What are the key outcomes of Porter's five forces model?

8.    Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

·         The report offers comprehensive data on the Equine Pharmaceuticals and Supplements market elaborating on the current state and future growth prospects both globally and regionally

·         It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth

·         The report offers deep-dive insights into each market segment and critical factors responsible for its growth

·         The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position

·         The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions

·         Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope

 

·         The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies.

Chapter 1.  Executive Summary

1.1.   Market Outlook

1.2.   Market Segment Outlook

1.3.   Geography Outlook

1.4.   Absolute $ Opportunity

Chapter 2.  Research Methodology

2.1.   Research Approach

2.2.   Scope, Definition, and Assumptions

2.3.   Data Sources

2.3.1. Secondary Sources

2.3.1.1.         Preliminary Data Mining

2.3.2. Primary Sources

2.3.2.1.         Statistical Distribution Channel

2.3.2.2.         Data Triangulation

2.3.2.3.         Research Objective

Chapter 3.  Market Outlook

3.1.   Introduction

3.2.   Key Trends

3.2.1. Product Type Trends

3.2.2. Application Trends

3.2.3. Distribution Channel Trends

3.3.   Market Dynamics

3.3.1. Market Drivers

3.3.1.1.         Impact Analysis of Market Drivers

3.3.2. Market Restraints

3.3.2.1.         Impact Analysis of Market Restraints

3.3.3. Market Opportunities

3.3.3.1.         Impact Analysis of Market Opportunities

3.3.4. Market Challenges

3.3.4.1.         Impact Analysis of Market Challenges

3.4.   Porter’s Five Forces’ Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of New Entrant

3.4.4. Threat of Substitutes

3.4.5. Competitive Rivalry

3.5.   Value Chain Analysis: Global Equine Pharmaceuticals and Supplements Market

3.6.   COVID-19 Impact Assessment in Equine Pharmaceuticals and Supplements Market

3.6.1. Impact Assessment on Global Equine Pharmaceuticals and Supplements Market

3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4.  Global Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

4.1.   Global Equine Pharmaceuticals and Supplements Market Share, By Product Type, 2017 - 2028 (USD Million)

4.1.1. Pharmaceuticals

4.1.1.1.         Anti-Inflammatory

4.1.1.2.         Anti-Ulcer Drugs

4.1.1.3.         Sedative/Tranquilizer

4.1.1.4.         Others

4.1.2. Supplements

4.1.2.1.         Proteins / Amino Acids

4.1.2.2.         Vitamins

4.1.2.3.         Enzymes

4.1.2.4.         Electrolytes & Minerals

4.1.2.5.         Others

Chapter 5.  Global Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

5.1.   Global Equine Pharmaceuticals and Supplements Market Share, By Application, 2017 - 2028 (USD Million)

5.1.1. Thoroughbred Horse

5.1.2. Others

Chapter 6.  Global Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

6.1.   Global Equine Pharmaceuticals and Supplements Market Share, By Distribution Channel, 2017 - 2028 (USD Million)

6.1.1. Third Party E-commerce Website

6.1.2. Company Websites

6.1.3. Specialty Stores

6.1.4. Others

Chapter 7.  Global Equine Pharmaceuticals and Supplements Market Overview, By Geography, 2017 - 2028 (USD Million)

7.1.   Global Equine Pharmaceuticals and Supplements Market Share, By Geography, 2017 - 2028 (USD Million)

7.1.1. Market Application and Projections, by Countries, 2017 - 2028 (USD Million)

7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 8.  North America Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

8.1.     North America Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

8.1.1.     Market Application and projections, 2017 - 2028 (USD Million)

8.1.2.     North America Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

8.1.3.     North America Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

8.1.4.     North America Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

8.2.     North America Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

8.2.1.     U.S. Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

8.2.1.1.         U.S. Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

8.2.1.2.         U.S. Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

8.2.1.3.         U.S. Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

8.2.2.     Canada Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

8.2.2.1.         Canada Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

8.2.2.2.         Canada Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

8.2.2.3.         Canada Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

8.2.3.     Mexico Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

8.2.3.1.         Mexico Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

8.2.3.2.         Mexico Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

8.2.3.3.         Mexico Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 9.  Europe Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

9.1.     Europe Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.1.1. Market Application and projections, 2017 - 2028 (USD Million)

9.1.2.     Europe Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.1.3.     Europe Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.1.4.     Europe Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.     Europe Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

9.2.1.     Germany Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.1.1.         Germany Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.1.2.         Germany Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.1.3.         Germany Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.2.     France Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.2.1.         France Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.2.2.         France Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.2.3.         France Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.3.     UK Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.3.1.         UK Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.3.2.         UK Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.3.3.         UK Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.4.     Italy Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.4.1.         Italy Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.4.2.         Italy Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.4.3.         Italy Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.5.     Spain Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.5.1.         Spain Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.5.2.         Spain Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.5.3.         Spain Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.6.     NORDIC Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.6.1.         NORDIC Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.6.2.         NORDIC Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.6.3.         NORDIC Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.7.     Russia and CIS Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.7.1.         Russia and CIS Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.7.2.         Russia and CIS Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.7.3.         Russia and CIS Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

9.2.8.     Rest of Europe Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

9.2.8.1.         Rest of Europe Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

9.2.8.2.         Rest of Europe Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.8.3.         Rest of Europe Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 10.      Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

10.1.  Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.1.1.   Market Application and projections, 2017 - 2028 (USD Million)

10.1.2.   Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.1.3.   Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.1.4.   Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

10.2.  Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

10.2.1.   India Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.2.1.1.       India Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.2.1.2.       India Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.1.3.       India Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

10.2.2.   China Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.2.2.1.       China Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.2.2.2.       China Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.2.3.       China Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

10.2.3.   Japan Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.2.3.1.       Japan Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.2.3.2.       Japan Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.3.3.       Japan Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

10.2.4.   ASEAN Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.2.4.1.       ASEAN Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.2.4.2.       ASEAN Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.4.3.       ASEAN Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

10.2.5.   South Korea Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.2.5.1.       South Korea Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.2.5.2.       South Korea Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.5.3.       South Korea Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

10.2.6.   Australia Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.2.6.1.       Australia Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.2.6.2.       Australia Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.6.3.       Australia Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

10.2.7.   Rest of Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

10.2.7.1.       Rest of Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

10.2.7.2.       Rest of Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.7.3.       Rest of Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 11.      South America Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

11.1.  South America Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

11.1.1.   Market Application and projections, 2017 - 2028 (USD Million)

11.1.2.   South America Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

11.1.3.   South America Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

11.1.4.   South America Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

11.2.  South America Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

11.2.1.   Brazil Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

11.2.1.1.       Brazil Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

11.2.1.2.       Brazil Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.1.3.       Brazil Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

11.2.2.   Argentina Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

11.2.2.1.       Argentina Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

11.2.2.2.       Argentina Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.2.3.       Argentina Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

11.2.3.   Rest of South America Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

11.2.3.1.       Rest of South America Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

11.2.3.2.       Rest of South America Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.3.3.       Rest of South America Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 12.      Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

12.1.  Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

12.1.1.   Market Application and projections, 2017 - 2028 (USD Million)

12.1.2.   Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

12.1.3.   Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

12.1.4.   Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

12.2.  Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Countries, 2017 - 2028 (USD Million)

12.2.1.   GCC Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

12.2.1.1.       GCC Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

12.2.1.2.       GCC Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

12.2.1.3.       GCC Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

12.2.2.   South Africa Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

12.2.2.1.       South Africa Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

12.2.2.2.       South Africa Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

12.2.2.3.       South Africa Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

12.2.3.   Rest of Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, 2017 - 2028 (USD Million)

12.2.3.1.       Rest of Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Product Type, 2017 - 2028 (USD Million)

12.2.3.2.       Rest of Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Application, 2017 - 2028 (USD Million)

12.2.3.3.       Rest of Middle East & Africa Equine Pharmaceuticals and Supplements Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 13.      Competitive Landscape

13.1.  Competitive Environment, 2021

13.2.  Strategic Framework

13.2.1.   Partnership/Collaborations/Agreement

13.2.2.   Expansion

13.2.3.   Mergers & Acquisitions

13.2.4.   New Product Development

Chapter 14.      Key Vendor Analysis

14.1.              Boehringer Ingelheim

14.1.1.       Business Overview

14.1.2.       Product Benchmarking

14.1.3.       Financial Data

14.1.4.       Strategic Overview

14.1.5.       Key Developments

14.1.6.       SWOT Analysis

14.2.              Merck Animal Health

14.2.1.       Business Overview

14.2.2.       Product Benchmarking

14.2.3.       Financial Data

14.2.4.       Strategic Overview

14.2.5.       Key Developments

14.2.6.       SWOT Analysis

14.3.              Zoetis

14.3.1.       Business Overview

14.3.2.       Product Benchmarking

14.3.3.       Financial Data

14.3.4.       Strategic Overview

14.3.5.       Key Developments

14.3.6.       SWOT Analysis

14.4.              Bayer Animal Health

14.4.1.       Business Overview

14.4.2.       Product Benchmarking

14.4.3.       Financial Data

14.4.4.       Strategic Overview

14.4.5.       Key Developments

14.4.6.       SWOT Analysis

14.5.              Elanco Animal Health

14.5.1.       Business Overview

14.5.2.       Product Benchmarking

14.5.3.       Financial Data

14.5.4.       Strategic Overview

14.5.5.       Key Developments

14.5.6.       SWOT Analysis

14.6.              Dechra Veterinary Products

14.6.1.       Business Overview

14.6.2.       Product Benchmarking

14.6.3.       Financial Data

14.6.4.       Strategic Overview

14.6.5.       Key Developments

14.6.6.       SWOT Analysis

14.7.              CEVA

14.7.1.       Business Overview

14.7.2.       Product Benchmarking

14.7.3.       Financial Data

14.7.4.       Strategic Overview

14.7.5.       Key Developments

14.7.6.       SWOT Analysis

14.8.              Virbac

14.8.1.       Business Overview

14.8.2.       Product Benchmarking

14.8.3.       Financial Data

14.8.4.       Strategic Overview

14.8.5.       Key Developments

14.8.6.       SWOT Analysis

14.9.              Norbrook Equine

14.9.1.       Business Overview

14.9.2.       Product Benchmarking

14.9.3.       Financial Data

14.9.4.       Strategic Overview

14.9.5.       Key Developments

14.9.6.       SWOT Analysis

14.10.            Kyoritsu Seiyaku

14.10.1.    Business Overview

14.10.2.    Product Benchmarking

14.10.3.    Financial Data

14.10.4.    Strategic Overview

14.10.5.    Key Developments

14.10.6.    SWOT Analysis

14.11.            Vetoquinol

14.11.1.    Business Overview

14.11.2.    Product Benchmarking

14.11.3.    Financial Data

14.11.4.    Strategic Overview

14.11.5.    Key Developments

14.11.6.    SWOT Analysis

14.12.            Protexin Healthcare

14.12.1.    Business Overview

14.12.2.    Product Benchmarking

14.12.3.    Financial Data

14.12.4.    Strategic Overview

14.12.5.    Key Developments

14.12.6.    SWOT Analysis

14.13.            Audevard

14.13.1.    Business Overview

14.13.2.    Product Benchmarking

14.13.3.    Financial Data

14.13.4.    Strategic Overview

14.13.5.    Key Developments

14.13.6.    SWOT Analysis

14.14.            Ouro Fino Saude

14.14.1.    Business Overview

14.14.2.    Product Benchmarking

14.14.3.    Financial Data

14.14.4.    Strategic Overview

14.14.5.    Key Developments

14.14.6.    SWOT Analysis

Chapter 15.   Future Outlook of the Market